Why it Matters
The House Science, Space, and Technology Committee will convene Wednesday, July 22 for a hearing titled "Unleashing Golden Age Science," examining how the fiscal year 2027 research and technology enterprise will be funded and protected. The stakes stretch from national laboratories facing foreign pressure to merit-based science funding facing political scrutiny, with the outcome shaping how competitive American research institutions remain heading into the next fiscal year.
The Big Picture
Recent weeks have surfaced competing pressures on U.S. science policy. Rep. Claudia Tenney (R-NY) introduced legislation designed to protect America's national laboratories from foreign adversaries, signaling concern about the security of sensitive research. Meanwhile, Rep. Seth Moulton (D-MA) led Massachusetts colleagues in urging the Office of Management and Budget to shield merit-based federal research funding from politicization.
On the investment side, federal backing for research continues. Sen. Chuck Schumer (D-NY), Sen. Kirsten Gillibrand (D-NY), and Rep. Joseph Morelle (D-NY) announced a $15 million federal award for the University of Rochester's laser discovery research, reflecting ongoing commitment to specific research initiatives.
Universities are already positioning themselves for fiscal year 2027 appropriations. Florida State University lobbied on the Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act), fiscal year 2027 appropriations bills, and Golden Dome funding opportunities during quarter one of 2026, suggesting institutions are mobilizing to shape budget outcomes before Congress finalizes priorities.
The Bottom Line
Michael Kratsios, Director of the White House Office of Science and Technology Policy, is set to testify as the hearing's sole announced witness, giving the administration a direct platform to lay out its fiscal year 2027 research priorities. Ranking Member Rep. Zoe Lofgren (D-CA) is slated to deliver the opening statement for the minority.
Rep. Chuck Fleischmann (R-TN), who chairs the House Appropriations Committee's subcommittee overseeing energy and water development, sits on both the full science committee and its energy subcommittee, giving him direct influence over how federal research dollars eventually flow to those sectors. With lawmakers, universities, and lobbyists all jockeying ahead of fiscal year 2027 appropriations, and the administration's science chief set to testify, this hearing is likely to set an early marker for how Congress balances research investment against security and political concerns in the year ahead.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article